Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
Orders placed before 3pm are typically dispatched the same business day on business days
Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial
Tatiana Habanova Dr
Watson, F
This peptide modulates the effects of nitric oxide, a crucial molecule involved in blood vessel function
Discovery of a potent and orally active dual GPBAR1/CysLT1R modulator for the treatment of metabolic fatty liver disease
US$ 27.85
US$ 21.28
US$ 27.96
